Literature DB >> 33029790

Travel restrictions and evidence-based decision making for novel epidemics.

Jessica Stanhope1, Philip Weinstein1.   

Abstract

Entities:  

Keywords:  COVID-19; Evidence-based medicine; Infectious diseases; Respiratory tract infections; Travel medicine

Mesh:

Year:  2020        PMID: 33029790      PMCID: PMC7675635          DOI: 10.5694/mja2.50803

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
to the editor: Travel restrictions to control the transmission of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus that causes coronavirus disease 2019 (COVID‐19), were rapidly implemented in Australia. Despite its apparent efficacy, this proactive approach has been criticised as unscientific and in breach of the International Health Regulations. A recently published comment claimed that travel restrictions were implemented without supporting scientific evidence and had “been challenged by public health researchers”, citing research on Ebola and influenza. However, their interpretation is not consistent with an evidence‐based approach. When managing a novel infection, evidence‐based decision making should (i) use the best available relevant information that is generalisable to the novel infection — for example, an infection with a similar route of transmission; that is, not Ebola, but rather severe acute respiratory syndrome (SARS), influenza, and Middle East respiratory syndrome (MERS) — and (ii) clearly define the outcome of interest (eg, prevention v delay). A recent review of travel restrictions for emerging infectious diseases, including SARS and MERS, found only one study regarding coronaviruses. The evidence identified supports the use of air travel bans to prevent the spread of coronavirus epidemics. Furthermore, systematic reviews, , , including the review cited in the comment, have reported that travel restrictions delayed, but did not prevent, the spread of influenza. , These delays were up to 4 months, and up to 10 months if implemented in combination with other local strategies. At the start of the COVID‐19 pandemic, this reflected the best available evidence to make evidence‐based decisions regarding travel restrictions. The evidence suggests that travel restrictions may, therefore, be used to delay and attenuate the peak in case numbers to reduce the burden on the health system, allowing for preparations to be made to better manage the outbreak. The preparation measures may include upskilling the health care workforce, building new facilities, improving access to laboratory testing and ventilators, and stockpiling personal protective equipment. This is the primary goal of travel restrictions as public health interventions. We conclude that Australia's rapid introduction of travel restrictions is consistent with an evidence‐based approach that prioritises the precautionary principle and saving lives.

Competing interests

No relevant disclosures.
  5 in total

Review 1.  An integrative review of the limited evidence on international travel bans as an emerging infectious disease disaster control measure.

Authors:  Nicole A Errett; Lauren M Sauer; Lainie Rutkow
Journal:  J Emerg Manag       Date:  2020 Jan/Feb

Review 2.  Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review.

Authors:  Ana L P Mateus; Harmony E Otete; Charles R Beck; Gayle P Dolan; Jonathan S Nguyen-Van-Tam
Journal:  Bull World Health Organ       Date:  2014-09-29       Impact factor: 9.408

3.  Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-International Travel-Related Measures.

Authors:  Jaspreet Pannu
Journal:  Emerg Infect Dis       Date:  2020-06-03       Impact factor: 6.883

Review 4.  Combination strategies for pandemic influenza response - a systematic review of mathematical modeling studies.

Authors:  Vernon J Lee; David C Lye; Annelies Wilder-Smith
Journal:  BMC Med       Date:  2009-12-10       Impact factor: 8.775

5.  Do not violate the International Health Regulations during the COVID-19 outbreak.

Authors:  Roojin Habibi; Gian Luca Burci; Thana C de Campos; Danwood Chirwa; Margherita Cinà; Stéphanie Dagron; Mark Eccleston-Turner; Lisa Forman; Lawrence O Gostin; Benjamin Mason Meier; Stefania Negri; Gorik Ooms; Sharifah Sekalala; Allyn Taylor; Alicia Ely Yamin; Steven J Hoffman
Journal:  Lancet       Date:  2020-02-13       Impact factor: 79.321

  5 in total
  1 in total

1.  Classification Schemes of COVID-19 High Risk Areas and Resulting Policies: A Rapid Review.

Authors:  Olalekan A Uthman; Olatunji O Adetokunboh; Charles Shey Wiysonge; Sameh Al-Awlaqi; Johanna Hanefeld; Charbel El Bcheraoui
Journal:  Front Public Health       Date:  2022-02-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.